🚀 Enjoy a 7-Day Free Trial Thru Jan 04, 2025! ✨

Nykode Therapeutics AS

OTCPK:VACBF (Norway) Ordinary Shares

$ 0.24 0 (0%) 11:09 PM EST

At Loss

0.65

$ 85.22M

$ -33.48M

Volume:

-

Avg Vol (2M):

4.64K

Warning! GuruFocus detected 4 Severe warning signs with VACBF. Try a 7-Day Free Trial to check it out.

Trade In:

Volume:

-

85.22M

At Loss

Avg Vol (2M):

4.64K

Enterprise Value $:

-33.48M

0.65

Nykode Therapeutics AS Valuation Measures

Category Alphabet

Fundamental (48)

Altman Z2-Score

Beneish M-Score

Book Value per Share

Cyclically Adjusted Book per Share

Cyclically Adjusted FCF per Share

Cyclically Adjusted Revenue per Share

Dividends per Share

Earnings per Share (Diluted)

EBITDA per Share

Enterprise Value

EPS without NRI

Financial Strength

Float Percentage Of Total Shares Outstanding

Free Cash Flow per Share

Insider Ownership

Institutional Ownership

Mohanram G-Score

Net Cash per Share

Net Current Asset Value

Net-Net Working Capital

Operating Cash Flow per Share

Owner Earnings per Share (TTM)

Piotroski F-Score

Predictability Rank

Probability of Financial Distress (%)

Profitability Rank

Revenue per Share

Risk Assessment

Scaled Net Operating Assets

Short Percentage of Float

Tangible Book per Share

Total Debt per Share

YoY EBITDA Growth

YoY Rev. per Sh. Growth

Valuation Ratio (78)

10-Year ROIIC %

Buyback Yield %

Capex-to-Operating-Cash-Flow

Capex-to-Operating-Income

Capex-to-Revenue

Cash Conversion Cycle

COGS-to-Revenue

Cyclically Adjusted PB Ratio

Cyclically Adjusted Price-to-FCF

Cyclically Adjusted PS Ratio

Days Sales Outstanding

Debt-to-Revenue

Degree of Financial Leverage

Degree of Operating Leverage

Earnings Yield %

Earnings Yield (Joel Greenblatt) %

Effective Interest Rate on Debt %

Equity-to-Asset

Forward PE Ratio

Forward Rate of Return (Yacktman) %

Goodwill-to-Asset

Gross-Profit-to-Asset %

Interest Coverage

Inventory Turnover

Inventory-to-Revenue

Liabilities-to-Assets

LT-Debt-to-Total-Asset

Net Debt Paydown Yield %

PE Ratio without NRI

Price-to-Free-Cash-Flow

Price-to-Funds-From-Operations

Price-to-Operating-Cash-Flow

Price-to-Owner-Earnings

Price-to-Tangible-Book

Receivables Turnover

Return-on-Tangible-Asset

Return-on-Tangible-Equity

ROC (Joel Greenblatt) %

ROE % Adjusted to Book Value

Shareholder Yield %

Shares Buyback Ratio %

Shiller PE Ratio

Total Payout Ratio

Total Payout Yield %

Profitability (7)

EBITDA Margin %

Net Interest Margin (Bank Only) %

Operating Margin %

Pretax Margin %

3-Year Dividend Growth Rate

5-Year Dividend Growth Rate

5-Year Yield-on-Cost %

Dividend Payout Ratio

Dividend Yield %

Dividend-Payout-to-FFO

Forward Dividend Yield %

Income Statement (47)

Cost of Goods Sold

Credit Losses Provision

Depreciation, Depletion and Amortization

Fees and Other Income

General and Admin. Expense

Interest Expense

Interest Expense (Positive)

Interest Income

Net Income (Continuing Operations)

Net Income (Discontinued Operations)

Net Income Including Noncontrolling Interests

Net Interest Income

Net Interest Income (for Banks)

Net Investment Income

Net Policyholder Benefits/Claims

Non Interest Income

Non Operating Income

Operating Income

Other Income (Expense)

Other Income (Minority Interest)

Other Net Income (Loss)

Other Noninterest Expense

Other Operating Expense

Policy Acquisition Expense

Preferred Dividends

Research & Development

Selling and Marketing Expense

Selling, General, & Admin. Expense

Shares Outstanding (Basic Average)

Shares Outstanding (Diluted Average)

Total Noninterest Expense

Total Operating Expense

Total Premiums Earned

Balance Sheet (83)

Accounts Payable

Accounts Payable & Accrued Expense

Accounts Payable & Accrued Expense for Financial Companies

Accounts Receivable

Accumulated Depreciation

Accumulated other comprehensive income (loss)

Additional Paid-In Capital

Allowance For Loans And Lease Losses

Balance Sheet Cash And Cash Equivalents

Buildings And Improvements

Cash And Cash Equivalents

Cash, Cash Equivalents, Marketable Securities

Construction In Progress

Current Accrued Expense

Current Deferred Revenue

Current Deferred Taxes Liabilities

Deferred Policy Acquisition Costs

DeferredTaxAndRevenue

Equity Investments

Fixed Maturity Investment

Future Policy Benefits

Gross Property, Plant and Equipment

Intangible Assets

Inventories, Finished Goods

Inventories, Inventories Adjustments

Inventories, Other

Inventories, Raw Materials & Components

Inventories, Work In Process

Investments And Advances

Land And Improvements

Loans Receivable

Long-Term Capital Lease Obligation

Long-Term Debt & Capital Lease Obligation

Machinery, Furniture, Equipment

Marketable Securities

Minority Interest

Money Market Investments

NonCurrent Deferred Liabilities

Notes Receivable

Other Assets for Banks

Other Assets for Insurance Companies

Other Current Assets

Other Current Liabilities

Other Current Payables

Other Current Receivables

Other Gross PPE

Other Liabilities for Banks

Other Liabilities for Insurance Companies

Other Long Term Assets

Other Long-Term Liabilities

Other Stockholders Equity

PensionAndRetirementBenefit

Policyholder Funds

Preferred Stock

Property, Plant and Equipment

Retained Earnings

Securities & Investments

Shares Outstanding (EOP)

Short-Term Capital Lease Obligation

Short-Term Debt

Short-Term Debt & Capital Lease Obligation

Short-term investments

Total Current Assets

Total Current Liabilities

Total Inventories

Total Liabilities

Total Long-Term Assets

Total Long-Term Liabilities

Total Receivables

Total Stockholders Equity

Total Tax Payable

Unearned Income

Unearned Premiums

Unpaid Loss & Loss Reserve

Cashflow statement (66)

Asset Impairment Charge

Beginning Cash Position

Capital Expenditure

Cash Flow for Dividends

Cash Flow for Lease Financing

Cash Flow from Discontinued Operations

Cash Flow from Financing

Cash Flow from Investing

Cash Flow from Operations

Cash Flow from Others

Cash From Discontinued Investing Activities

Cash from Discontinued Operating Activities

Cash From Other Investing Activities

Cash Paid for Insurance Activities

Cash Payments for Deposits by Banks and Customers

Cash Payments for Loans

Cash Receipts from Deposits by Banks and Customers

Cash Receipts from Fees and Commissions

Cash Receipts from Loans

Cash Receipts from Operating Activities

Cash Receipts from Securities Related Activities

Cash Receipts from Tax Refunds

Cash Received from Insurance Activities

Change In Inventory

Change In Other Working Capital

Change In Payables And Accrued Expense

Change In Prepaid Assets

Change In Receivables

Change In Working Capital

Depreciation, Depletion and Amortization

Dividends Received

Effect of Exchange Rate Changes

Ending Cash Position

Interest and Commission Paid

Interest Received

Issuance of Debt

Issuance of Stock

Net Change in Cash

Net Income From Continuing Operations

Net Intangibles Purchase And Sale

Net Issuance of Debt

Net Issuance of Preferred Stock

Other Cash Payments from Operating Activities

Other Cash Receipts from Operating Activities

Other Financing

Payments of Debt

Payments on Behalf of Employees

Payments to Suppliers for Goods and Services

Purchase Of Business

Purchase Of Investment

Purchase Of Property, Plant, Equipment

Receipts from Customers

Receipts from Government Grants

Repurchase of Stock

Sale Of Business

Sale Of Investment

Sale Of Property, Plant, Equipment

Stock Based Compensation

Taxes Refund Paid

Technical Indicator (8)

12-1 Month Momentum %

3-1 Month Momentum %

6-1 Month Momentum %

6-Month Price Index

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Follow Us

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.